Pulsatile gonadotropin-releasing hormone therapy induces spermatogenesis in pituitary stalk interruption syndrome: A case report and review of the literature

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 20

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-4)

Sum=0

Jul 16, 2024 (publication date) through Jun 30, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Jul 16, 2024; 12(20): 4348-4356
Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4348

Table 2 Results of gonadal steroids

FSH: Follicle stimulating hormone; LH: Luteinizing hormone; T: Testosterone; E2: Estradiol; PRL: Prolactin.

Citation: Xie JL, Zhu HY, Dong Y, Sun PP, Qi DD, Luan SX, Zhang Y, Ma HG. Pulsatile gonadotropin-releasing hormone therapy induces spermatogenesis in pituitary stalk interruption syndrome: A case report and review of the literature. World J Clin Cases 2024; 12(20): 4348-4356
URL: https://www.wjgnet.com/2307-8960/full/v12/i20/4348.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i20.4348